An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia

Clinical Infectious Diseases

Volumn 65, Issue 2, 2017, Pages 194-200

  Wenzler, Eric ^a   Wang, Fei ^b   Goff, Debra A ^b   Prier, Beth ^b   Mellett, John ^b   Mangino, Julie E ^c   Bauer, Karri A ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Department of Pharmacy ^*  (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

bacteremia; pharmacist; process measure; quality of care.; Staphylococcus aureus

Indexed keywords

CEFAZOLIN; CEFTAROLINE; DAPTOMYCIN; NAFCILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; AUTOMATION; BLOOD CULTURE; CLINICAL PHARMACY; COMORBIDITY; CONTINUOUS INFUSION; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE QUALITY; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS BACTEREMIA; MICROBIOLOGY; OUTCOME ASSESSMENT; PHARMACIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RETROSPECTIVE STUDY; SCOPE OF PRACTICE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; WORKLOAD; ADOLESCENT; ANTIMICROBIAL STEWARDSHIP; BACTEREMIA; DISEASE MANAGEMENT; DRUG EFFECT; ELECTRONIC HEALTH RECORD; EVIDENCE BASED MEDICINE; HOSPITAL PHARMACY; HOSPITALIZATION; MIDDLE AGED; PATIENT REFERRAL; STAPHYLOCOCCUS INFECTION; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; BACTEREMIA; DISEASE MANAGEMENT; ELECTRONIC HEALTH RECORDS; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHARMACY SERVICE, HOSPITAL; PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85023200373     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix315     Document Type: Article

References (29)

1. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28:603-61
2. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362-86
3. Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015; 60:1451-61
4. Choi SH, Cho SY, Park JH, Chung JW. Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia. J Infect 2011; 62:181-5
5. Forsblom E, Ruotsalainen E, Ollgren J, Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 56:527-35
6. Fries BL, Licitra C, Crespo A, et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2014; 58:598-9
7. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010; 123:631-7
8. Isobe M, Uejima E, Seki M, et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother 2012; 18:841-7
9. Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine 2009; 88:263-7
10. Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16:1783-8
11. Pastagia M, Kleinman LC, Lacerda Cruz EG, Jenkins SG. Predicting risk for death from MRSA bacteremia. Emerg Infect Dis 2012; 18:1072-80
12. Rieg S, Peyerl-Hoffmann G, With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-A study of 521 patients in Germany. J Infect 2009; 59:232-9
13. Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012; 31:2421-8
14. Tissot F, Calandra T, Prod'hom G, et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect 2014; 69:226-34
15. Chandrasekar P, Havlichek D, Johnson LB. Infectious diseases subspecialty: declining demand challenges and opportunities. Clin Infect Dis 2014; 59:1593-8
16. Howard P, Pulcini C, Levy Hara G, et al.; ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother 2015; 70:1245-55
17. The Joint Commission. Proposed standard for antimicrobial stewardship in AHC, CAH, HAP, NCC, and OBS. 2015. Available at http://jointcommission.az1.qualtrics. com/CP/File.php?F=F-5tDHGzIVDMHenDn. Accessed 27 September 2016
18. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016; 60:4840-52
19. Nguyen CT, Gandhi T, Chenoweth C, et al. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study. J Antimicrob Chemother 2015; 70:3390-6
20. Forrest GN, Van Schooneveld TC, Kullar R, Schulz LT, Duong P, Postelnick M. Use of electronic health records and clinical decision support systems for antimicrobial stewardship. Clin Infect Dis 2014; 59(suppl 3):S122-33
21. Hamilton KW, Gerber JS, Moehring R, et al.; Centers for Disease Control and Prevention Epicenters Program. Point-of-prescription interventions to improve antimicrobial stewardship. Clin Infect Dis 2015; 60:1252-8
22. Carreno JJ, Kenney RM, Bloome M, et al. Evaluation of pharmacy generalists performing antimicrobial stewardship services. Am J Health Syst Pharm 2015; 72:1298-303
23. Waters CD. Pharmacist-driven antimicrobial stewardship program in an institution without infectious diseases physician support. Am J Health Syst Pharm 2015; 72:466-8
24. Nanosphere Inc. Verigene® Gram-positive blood culture nucleic acid test (BCGP) package insert. Northbrook, IL: Nanosphere Inc., 2012
25. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus Aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55
26. Jordan TA, Hennenfent JA, Lewin JJ 3rd, Nesbit TW, Weber R. Elevating pharmacists' scope of practice through a health-system clinical privileging process. Am J Health Syst Pharm 2016; 73:1395-405
27. Lopez-Cortes LE, Del Toro MD, Galvez-Acebal J, et al.; REIPI/SAB group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 57:1225-33
28. Borde JP, Batin N, Rieg S, et al. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 2014; 42:713-9
29. Vogel M, Schmitz RP, Hagel S, et al. Infectious disease consultation for Staphylococcus aureus bacteremia-A systematic review and meta-analysis. J Infect 2016; 72:19-28